Immix Biopharma logo

Immix Biopharma Share Price (NASDAQ: IMMX)

$2.23

-0.06

(-2.62%)

Last updated on

Check the interactive Immix Biopharma Stock chart to analyse performance

Immix Biopharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.20
    Today's High:$2.30

    Day's Volatility :4.35%

  • 52 Weeks Low:$1.26
    52 Weeks High:$3.20

    52 Weeks Volatility :60.63%

Immix Biopharma Stock Returns

PeriodImmix Biopharma IncIndex (Russel 2000)
3 Months
-14.23%
0.0%
6 Months
37.65%
0.0%
1 Year
9.31%
0.0%
3 Years
20.54%
-4.7%

Immix Biopharma Inc Key Stats

Check Immix Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.29
Open
$2.26
Today's High
$2.3
Today's Low
$2.2
Market Capitalization
$66.0M
Today's Volume
$148.4K
52 Week High
$3.2
52 Week Low
$1.26
Revenue TTM
$0.0
EBITDA
$-23.7M
Earnings Per Share (EPS)
$-0.77
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-162.04%

Stock Returns calculator for Immix Biopharma Stock including INR - Dollar returns

The Immix Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immix Biopharma investment value today

Current value as on today

₹1,14,598

Returns

₹14,598

(+14.6%)

Returns from Immix Biopharma Stock

₹9,314 (+9.31%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Immix Biopharma Stock

100%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Immix Biopharma Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immix Biopharma Inc

  • Name

    Holdings %

  • Bleichroeder LP

    2.99%

  • Cable Car Capital LLC

    2.74%

  • Vanguard Group Inc

    2.46%

  • Geode Capital Management, LLC

    0.57%

  • Northern Trust Corp

    0.34%

  • Morgan Stanley - Brokerage Accounts

    0.29%

Analyst Recommendation on Immix Biopharma Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Immix Biopharma(by analysts ranked 0 to 5 stars)

Immix Biopharma Share Price Target

What analysts predicted

Upside of 213.9%

Target:

$7.00

Current:

$2.23

Immix Biopharma share price target is $7.00, a slight Upside of 213.9% compared to current price of $2.23 as per analysts' prediction.

Immix Biopharma Stock Insights

  • Price Movement

    In the last 1 month, IMMX stock has moved down by -18.9%
  • IMMX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 65.7%
  • IMMX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 92.1%

Immix Biopharma Technicals Summary

Sell

Neutral

Buy

Immix Biopharma is currently in a neutral trading position according to technical analysis indicators.

Immix Biopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Immix Biopharma Inc logo
-18.01%
37.65%
9.31%
20.54%
-39.24%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Immix Biopharma Inc

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Organization
Immix Biopharma
Employees
18
CEO
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Industry
Miscellaneous

Key Management of Immix Biopharma Inc

NameTitle
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Co-Founder, CEO & Chairman
Mr. Gabriel Morris B.A.
CFO & Director
Dr. Graham Ross FFPM, M.D.
Chief Medical Officer & Head of Clinical Development
Mr. Sean Senn J.D., M.B.A., M.Sc., MBA, MSc
Co-Founder
Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.
Scientific Co-Founder
Dr. David Marks MBBS, Ph.D.
Chief Medical Officer of Cell Therapy

Important FAQs about investing in IMMX Stock from India :

What is Immix Biopharma share price today?

Immix Biopharma share price today is $2.23 as on at the close of the market. Immix Biopharma share today touched a day high of $2.30 and a low of $2.20.

What is the 52 week high and 52 week low for Immix Biopharma share?

Immix Biopharma share touched a 52 week high of $3.20 and a 52 week low of $1.26. Immix Biopharma stock price today i.e. is closed at $2.23, lower by 30.31% versus the 52 week high.

How to invest in Immix Biopharma Stock (IMMX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immix Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immix Biopharma Shares that will get you 0.6726 shares as per Immix Biopharma share price of $2.23 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immix Biopharma Stock (IMMX) from India?

Indian investors can start investing in Immix Biopharma (IMMX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Immix Biopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Immix Biopharma share’s latest price of $2.23 as on August 30, 2025 at 1:29 am IST, you will get 4.4843 shares of Immix Biopharma. Learn more about fractional shares .

What are the returns that Immix Biopharma has given to Indian investors in the last 5 years?

Immix Biopharma stock has given -39.24% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?